Aleix Elizalde Torrent
Aleix Elizalde-Torrent graduated in Medicine at the Universitat Autònoma de Barcelona in 2006. He did the residency in Internal Medicine at the Hospital Universitari de la Vall d’Hebron from 2007 to 2012, with a special training in Infectious Diseases and Tropical Medicine, and collaborating with the International Health Unit of the same hospital. This interest led him to achieve the "Diploma in Tropical Medicine & Hygiene” of the Liverpool School of Tropical Medicine.
After the residency, he joined the research group of Dr. Hernando del Portillo at the Barcelona Centre for International Health Research (CRESIB)/Barcelona Institute for Global Health (ISGlobal) as a PhD student. Fundamentally, his research was focused on understanding the role of the spleen and bone marrow in Plasmodium vivax malaria, with special attention to anemia and splenomegaly in this context. He performed part of this project in Manaus, Brazil.
Aleix Elizalde-Torrent obtained the International PhD in Medicine and Translational Research by the Universitat de Barcelona. He joined IrsiCaixa’s Microbial Genomics group as a post-doc. His research will focus on the influence of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation, and its underlying biological mechanisms.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
Sudden spleen rupture in a Plasmodium vivax-infected patient undergoing malaria treatment.
Spleen-Dependent Immune Protection Elicited by CpG Adjuvanted Reticulocyte-Derived Exosomes from Malaria Infection Is Associated with Changes in T cell Subsets' Distribution.